InsidersTradesSigma
Total declarations
Companies
▲ Purchases (160 ops.)
▼ Sales (55 ops.)
Insider track record
Board DirectorDisclosed buys
160
Disclosed sells
55
T+90 hit rate
46%
T+90 mean return
+6.5%
Across 41 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Opaleye Management Inc., Board Member. Director active across 14 companies, notably Eton Pharmaceuticals, Inc.. In total, 216 filings have been published. Breakdown: 160 buys · 55 sells. Total volume traded: €52.8m. Activity tracked since 25 May 2021. The latest transaction was disclosed on 14 July 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Opaleye Management Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations216 total
11,608 shares@ US$2.0853100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001493152-26-039124:0
Canonical exit: 12 Nov 2026 (T+90)
951 shares@ US$71.500.029% mcap1.7% of flowOrdinary Shares, par value NIS 1.00 per shareSEC:0001493152-26-038304:0
Canonical exit: 10 Nov 2026 (T+90)
2,900 shares@ US$7.92260.013% mcap0.6% of flowCommon Stock, no par valueSEC:0001493152-26-036015:0
Canonical exit: 29 Oct 2026 (T+90)
50,000 shares@ US$8.000.22% mcap10.0% of flowCommon Stock, no par valueSEC:0001493152-26-036015:1
Canonical exit: 1 Nov 2026 (T+90)
130 shares@ US$7.900.0006% mcap0.0% of flowCommon Stock, no par valueSEC:0001493152-26-035000:0
Canonical exit: 22 Oct 2026 (T+90)
10,000 shares@ US$7.83370.044% mcap2.2% of flowCommon Stock, no par valueSEC:0001493152-26-034560:1
Canonical exit: 20 Oct 2026 (T+90)
140,237 shares@ US$7.83370.61% mcap31.0% of flowCommon Stock, no par valueSEC:0001493152-26-034560:0
Canonical exit: 20 Oct 2026 (T+90)
49,849 shares@ US$7.79530.22% mcap10.9% of flowCommon Stock, no par valueSEC:0001493152-26-034560:2
Canonical exit: 21 Oct 2026 (T+90)
13,315 shares@ US$37.54310.048% mcap4.5% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-26-033818:1
15,000 shares@ US$37.54310.054% mcap5.1% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-26-033818:0
15,000 shares@ US$37.54310.054% mcap5.2% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-26-033577:0
13,315 shares@ US$37.54310.048% mcap4.6% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-26-033577:1
920 shares@ US$73.43040.028% mcap1.8% of flowOrdinary Shares, par value NIS 1.00 per shareSEC:0001493152-26-033354:1
Canonical exit: 12 Oct 2026 (T+90)
775 shares@ US$73.88730.024% mcap1.5% of flowOrdinary Shares, par value NIS 1.00 per shareSEC:0001493152-26-033354:0
Canonical exit: 11 Oct 2026 (T+90)
300 shares@ US$73.690.0089% mcap0.6% of flowOrdinary Shares, par value NIS 1.00 per shareSEC:0001493152-26-032859:0
Canonical exit: 6 Oct 2026 (T+90)
229 shares@ US$73.950.0068% mcap0.5% of flowOrdinary Shares, par value NIS 1.00 per shareSEC:0001493152-26-032859:1
Canonical exit: 8 Oct 2026 (T+90)
65,000 shares@ US$37.38510.24% mcap17.1% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-26-032394:0
25,000 shares@ US$37.38510.091% mcap6.6% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-26-032394:1
10,000 shares@ US$38.000.037% mcap2.7% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-26-032394:2
20,000 shares@ US$38.37280.074% mcap5.4% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-26-032394:3
6,685 shares@ US$38.37280.025% mcap1.8% of flowCommon Stock, par value $0.001 per shareSEC:0001493152-26-032394:4
197 sharesCommon Stock, no par valueSEC:0001493152-26-031063:0
Canonical exit: 23 Sept 2026 (T+90)
152,336 sharesCommon Stock, no par valueSEC:0001493152-26-031063:1
Canonical exit: 24 Sept 2026 (T+90)
2,862 sharesCommon Stock, no par valueSEC:0001493152-26-028783:0
Canonical exit: 9 Sept 2026 (T+90)
273 sharesCommon Stock, no par valueSEC:0001493152-26-028783:1
Canonical exit: 10 Sept 2026 (T+90)
25 of 216 declarations
About Opaleye Management Inc.
Opaleye Management Inc. is a Board Member linked to Alpha Cognition Inc., Tracon Pharmaceuticals, Inc., Protara Therapeutics, Inc., Sol-Gel Technologies Ltd., Eton Pharmaceuticals, Inc. and HARROW, INC., with 10% Owner roles for Alpha Cognition Inc., Sol-Gel Technologies Ltd. and Eton Pharmaceuticals, Inc. The entity has 200 filings in total. In the 200 sampled filings, transactions run from 2021-05-27 to 2026-07-10, with EUR 24802505 of buys and EUR 19288162 of sells, and the most frequent transaction nature is Acquisition.
